Home > Healthcare > Medical Devices > Diagnostic Devices > Home Sleep Apnea Testing Devices Market

Home Sleep Apnea Testing Devices Market Size

  • Report ID: GMI4439
  • Published Date: Aug 2022
  • Report Format: PDF

Home Sleep Apnea Testing Devices Market Size

Home Sleep Apnea Testing Devices Market size registered revenue over USD 810 million in 2021. The industry is projected to depict a CAGR of 16.8% through 2030, given the rising risks of chronic conditions such as heart diseases among patients with sleep disorders.

 

Sleep apnea tests can diagnose and calculate disease severity by monitoring the oxygen and breathing levels to measure the pauses in breathing across homecare settings. The rising number of patients diagnosed with sleep disorders and other associated co-morbidities will stimulate home sleep apnea testing devices market expansion. According to data from the American Sleep Association, nearly 50 million to 70 million U.S. adults have a sleep disorder, of which, 25 million are suffering from obstructive sleep apnea.

 

This expanding patient population is opting for devices with reliable and ergonomic designs that aid seamless at-home sleep apnea testing. For example, advanced, wearable sleep apnea testing devices with a user-friendly design, such as Lofta WatchPAT, have been made available for adults. The industry will therefore witness a strong growth trajectory, further influenced by the growing awareness about home sleep apnea tests among consumers.
 

Telemedicine has undergone technological advancements over recent years, ensuring seamless access to cost-effective treatments for sleep apnea and other diseases. As an alternative to traditional sleep studies conducted in labs, telemedicine options such as at-home sleep studies are becoming available to diagnose disease symptoms. It can also help patients select the right CPAP (continuous positive airway pressure) device and access ongoing monitoring. These innovations in telemedicine technologies will generate lucrative opportunities for market growth over the forecast period.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for home sleep apnea testing devices crossed USD 810 million in 2021 and is set to depict a CAGR of 16.8% through 2030.

The type 3 segment accounted for 65% of the home sleep testing devices industry share in 2021 and will be valued over USD 2,240 million by 2030, owing to its attributes such as portability, ease of use, and high sensitivity and specificity.

North America

The competitive landscape of the home sleep apnea testing devices industry is inclusive of companies such as Koninklijke Philips N.V., Compumedics Limited, Itamar Medical Inc., Natus Medical Inc., SOMNOmedics GmbH, Resmed, and Nox Medical, among others.

Home Sleep Apnea Testing Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 14
  • Tables & Figures: 81
  • Countries covered: 18
  • Pages: 95
 Download Free Sample